Company intelligence / Profile preview

Targeted Diagnostics & Therapeutics

West Chester, Pennsylvania, United Statespitchbook.com ↗

Ownership: Private
Employees: ~15
Development stage: Dissolved

Overview

Targeted Diagnostics & Therapeutics is developing molecular diagnostics and therapeutics, with a focus on colorectal cancer and other gastrointestinal diseases. Their pipeline has included a radiopharmaceutical imaging agent for solid tumors (discontinued) and an immunotherapeutic vaccine for colorectal cancer (pending clinical development). No recent clinical trial results are publicly available.

Therapeutic areas: Oncology
Modalities: VaccineRadiopharmaceuticalImmunostimulant
Industry: Biotech

Beyond the preview

Go deeper on Targeted Diagnostics & Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Targeted Diagnostics & Therapeutics.

Explore the full profile